IPP Bureau
Jubilant Ingrevia appoints Pravesh Kumar Garg as Chief of Manufacturing
By IPP Bureau - January 06, 2026
Pravesh brings with him over 29 years of experience in leading complex manufacturing operations and driving operational excellence
Thyrocare appoints Rajdeep Panwar as Chief Commercial Officer
By IPP Bureau - January 06, 2026
Rajdeep is an accomplished business leader with a strong techno-commercial background in the healthcare and diagnostic sector
Wegovy pill marks first GLP-1 weight-loss medicine in oral form
By IPP Bureau - January 06, 2026
The approval introduces a needle-free alternative to injectable GLP-1 therapies
PHARMEXCIL holds high-level talks with government to boost India’s pharma exports
By IPP Bureau - January 06, 2026
India’s pharmaceutical sector stands at a pivotal inflection point
Corewell Health, Quest Diagnostics finalize Michigan Lab JV
By IPP Bureau - January 06, 2026
The state-of-the-art laboratory opens at the Corewell Health Southfield Center in early 2027
Dabur sees early demand recovery, rural sales lead growth in Q3 FY26
By IPP Bureau - January 06, 2026
Within India, Dabur expects its Home & Personal Care business to deliver double-digit growth,
RedHill Biopharma advances RHB-102 as once-daily oral therapy to combat GLP-1 side effects
By IPP Bureau - January 06, 2026
The company is pursuing the accelerated FDA 505(b)(2) approval pathway for its once-daily oral ondansetron formulation
PathoCare Holdings valued at $1.75 billion following major third-party tender offer
By IPP Bureau - January 06, 2026
The company previously completed a $150 million venture investment, acquisition, and recapitalization
Nia Therapeutics unveils first implantable brain interface for memory disorders
By IPP Bureau - January 06, 2026
The SNS records neural activity from 60 channels across four brain regions—far exceeding current commercial devices
Singapore clears AI bladder cancer detection tool
By IPP Bureau - January 06, 2026
CystoSmart, an AI tool designed to detect bladder tumors during screening and surveillance cystoscopy, is brand-agnostic and works with flexible, rigid, and single-use scopes
Insilico Medicine teams up with Servier to fast-track AI-driven cancer drugs
By IPP Bureau - January 06, 2026
Under the agreement, Insilico could receive up to $32 million in upfront and near-term R&D payments
Valneva and Serum Institute end chikungunya vaccine partnership
By IPP Bureau - January 06, 2026
Valneva said regaining full rights to the vaccine will allow the company to “assume direct control over its supply chain and commercialization for endemic high-risk countries
BioInvent’s experimental combo shows promise in hard-to-treat ovarian cancer
By IPP Bureau - January 06, 2026
Pembrolizumab has shown meaningful benefit only when combined with chemotherapy
Abbott unveils Libre Assist to help meal management in diabetics
By IPP Bureau - January 06, 2026
Abbott’s latest innovation promises to shift diabetes management from reactive to proactive
Jaguar Health wins $240,000 FDA grant to advance dog cancer diarrhea treatment
By IPP Bureau - January 05, 2026
The company said it received notice on January 1 from the FDA’s Center for Veterinary Medicine that the funding will support its ongoing effectiveness study of Canalevia-CA1
